메뉴 바로가기
주메뉴 바로가기
컨텐츠 바로가기
Quratis

We hope to become a company with a social impact that leads the human public health.

Patent

Technology Title of Invention Status Number
Vaccine (TB Prevention) Vaccine composition for tuberculosis containing Rv0351 protein Registration 10-1624208
Vaccine composition for tuberculosis containing Rv3131 protein Registration 10-1579861
Vaccine composition for tuberculosis containing MTBK_24820 Registration 10-1568736
Vaccine composition for tuberculosis containing MTBK_20620 Registration 10-1672352
Vaccine composition for tuberculosis containing MTBK_20640 Registration 10-1705769
Vaccine composition for preventing tuberculosis containing a glycosylated Ag85A protein and method for producing the vaccine composition Prosecution 10-2019-0010431
Cell Therapy Platform (Dendritic Cell) Composition for treating and preventing of tuberculosis comprising dendritic cell and antibiotic agent Registration 10-1828044
Composition for boosting of tuberculosis vaccine comprising dendritic cell Registration 10-1892598
Pharmaceutical composition for preventing or treating hypersensitivity immune disease and the method for preparing thereof Registration 10-2003958
Maturation compositions of dendritic cell containing the Rv2299c protein or Rv2299c fused ESAT-6 protein Registration 10-1749165
Tolerorgenic plasmacytoid dendritic cells and the method for preparing thereof) Registration 10-1946572
Pharmaceutical composition for preventing or treating autoimmune disease and the method for preparing thereof) Registration 10-1893886
Peptide Nucleic Acid
(PNA)
Novel PNA and antibacterial composition comprising the same Registration 10-1501099
Novel PNA and antibacterial composition comprising the same Registration 10-1535874
STING Agonist Adjuvant and vaccine composition comprising STING agonist Registration 10-1982710
Adjuvant and vaccine composition comprising STING agonist Registration 10-2122955
TB Detection A multiplex PCR primer set, a composition and a kit comprising the same for diagnosing Mycobacterium tuberculosis and non-tuberculous mycobacteria Registration 10-1802417
Biomarker Biomarker for diagnosing infectious disease by nontuberculous mycobacteria Prosecution 10-2019-0151914
Biomarker for predicting the treatment response of inflammation by nontuberculous mycobacteria Prosecution 10-2019-0151915
Biomarker for predicting spontaneous bacteriuim negative after the infection by nontuberculous mycobacteria Prosecution 10-2019-0151924
Biomarker for predicting the prolonged positive result after the infection by nontuberculous mycobacteria Prosecution 10-2019-0151926
Biomarker for differentiating infectious disease by nontuberculous mycobacteria Prosecution 10-2019-0151931
Host directed treatment Composition for host directed treatment Prosecution 10-2019-0141597